Article information
Abstract
Cardiac comorbidity is one of the most important prognostic factors in lung disease, especially in chronic obstructive pulmonary disease (COPD). The imaging techniques available for the study of this systemic manifestation concomitant with COPD include heart catheterization, transthoracic echocardiography, and magnetic resonance imaging. Multidetector computed tomography (MDCT) represents a significant advance in this field because it enables the acquisition of simultaneous studies of the cardiopulmonary anatomy that go beyond anatomic and morphologic analysis to include a functional approach to this condition. In this article, we review the practical aspects necessary to evaluate cardiac comorbidity in patients with COPD, both from the point of view of pulmonary hypertension and of the analysis of ventricular dysfunction and coronary heart disease.
Keywords:
Computed tomography
Chronic obstructive pulmonary disease
Comorbidity
Heart disease
Resumen
La comorbilidad cardíaca es uno de los factores pronósticos más importantes en las enfermedades pulmonares, particularmente en la enfermedad pulmonar obstructiva crónica (EPOC). Entre las distintas técnicas de imagen disponibles para estudiar dicha manifestación sistémica concomitante a la EPOC se incluyen el cateterismo cardíaco, la ecocardiografía transtorácica y la resonancia magnética. La tomografía computarizada multidetector (TCMD) ha supuesto un progreso significativo en este campo, al permitir obtener estudios simultáneos de la anatomía cardiopulmonar que van más allá del análisis anatómico-morfológico e incluyen una aproximación funcional a dicha afectación. En este trabajo se repasan aspectos prácticos necesarios para valorar la comorbilidad cardíaca en pacientes con EPOC, tanto desde el punto de vista de la hipertensión pulmonar, como del análisis de la disfunción ventricular y de la enfermedad coronaria.
Palabras clave:
Tomografía computarizada
Enfermedad pulmonar obstructiva crónica
Comorbilidad
Enfermedad cardíaca
Article
These are the options to access the full texts of the publication Radiología (English Edition)
Subscriber
Purchase
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
References
[1]
Guía de práctica clínica de diagnóstico y tratamiento de la Enfermedad Pulmonar Obstructiva Crónica. SEPAR-ALAT.
(2009),
[2]
M. Miravitlles, J.B. Soriano, F. García-Río, L. Muñoz, E. Durán-Taulería, G. Sánchez, et al.
Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities.
Thorax, 64 (2009), pp. 863-868
[3]
W.M. Chatila, B.M. Thomashow, O.A. Minai, G.J. Criner, B.J. Make.
Comorbidities in chronic obstructive pulmonary disease.
Proc Am Thorac Soc, 5 (2008), pp. 549-555
[4]
J.C. Hogg.
Pathophysiology of airflow limitation in chronic obstructive pulmonary disease.
Lancet, 364 (2004), pp. 709-721
[5]
A.E. Camilli, D.R. Robbins, M.D. Lebowitz.
Death certificate reporting of confirmed airways obstructive disease.
Am J Epidemiol, 133 (1991), pp. 795-800
[6]
C. Schneider, U. Bothner, S.S. Jick, C.R. Meier.
Chronic obstructive pulmonary disease and the risk of cardiovascular diseases.
Eur J Epidemiol, 25 (2010), pp. 253-260
[7]
V. Fuster, L.E. Ryden, D.S. Cannom, H.J. Crijns, A.B. Curtis, K.A. Ellenbogen, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
Europace, 8 (2006), pp. 651-745
[8]
A.J. Taylor, M. Cerqueira, J.M. Hodgson, D. Mark, J. Min, P. O’Gara, ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography, et al.
A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance.
J Am Coll Cardiol, 56 (2010), pp. 1864-1894
[9]
T. Flohr, K. Stierstorfer, R. Raupach, S. Ulzheimer, H. Bruder.
Performance evaluation of a 64-slice CT system with z-flying focal spot.
Rofo, 176 (2004), pp. 1803-1810
[10]
M. Lell, F. Hinkmann, K. Anders, P. Deak, W.A. Kalender, M. Uder, et al.
High-pitch electrocardiogram-triggered computed tomography of the chest: initial results.
Invest Radiol, 44 (2009), pp. 728-733
[11]
E.A. Park, J.M. Goo, S.J. Park, H.J. Lee, C.H. Lee, C.M. Park, et al.
Chronic obstructive pulmonary disease: quantitative and visual ventilation pattern analysis at xenon ventilation CT performed by using a dual-energy technique.
Radiology, 256 (2010), pp. 985-997
[12]
S.F. Thieme, T.R. Johnson, C. Lee, J. McWilliams, C.R. Becker, M.F. Reiser, et al.
Dual-energy CT for the assessment of contrast material distribution in the pulmonary parenchyma.
Am J Roentgenol, 193 (2009), pp. 144-149
[13]
T. Henzler, M. Hanley, E. Arnoldi, G. Bastarrika, U.J. Schoepf, H.C. Becker.
Practical strategies for low radiation dose cardiac computed tomography.
J Thorac Imaging, 25 (2010), pp. 213-220
[14]
S. Leschka, P. Stolzmann, F.T. Schmid, H. Scheffel, B. Stinn, B. Marincek, et al.
Low kilovoltage cardiac dual-source CT: attenuation, noise, and radiation dose.
Eur Radiol, 18 (2008), pp. 1809-1817
[15]
H. Alkadhi, P. Stolzmann, H. Scheffel, L. Desbiolles, S. Baumuller, A. Plass, et al.
Radiation dose of cardiac dual-source CT: the effect of tailoring the protocol to patient-specific parameters.
Eur J Radiol, 68 (2008), pp. 385-391
[16]
W.P. Shuman, K.R. Branch, J.M. May, L.M. Mitsumori, J.N. Strote, B.H. Warren, et al.
Whole-chest 64-MDCT of emergency department patients with nonspecific chest pain: Radiation dose and coronary artery image quality with prospective ECG triggering versus retrospective ECG gating.
Am J Roentgenol, 192 (2009), pp. 1662-1667
[17]
T.C. Gerber, J.J. Carr, A.E. Arai, R.L. Dixon, V.A. Ferrari, A.S. Gomes, et al.
Ionizing radiation in cardiac imaging: a science advisory from the American Heart Association Committee on Cardiac Imaging of the Council on Clinical Cardiology and Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention.
Circulation, 119 (2009), pp. 1056-1065
[18]
D.B. Mark, D.S. Berman, M.J. Budoff, J.J. Carr, T.C. Gerber, H.S. Hecht, et al.
ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.
J Am Coll Cardiol, 55 (2010), pp. 2663-2699
[19]
T. Frauenfelder, P. Appenzeller, C. Karlo, H. Scheffel, L. Desbiolles, P. Stolzmann, et al.
Triple rule-out CT in the emergency department: protocols and spectrum of imaging findings.
Eur Radiol, 19 (2009), pp. 789-799
[20]
R. Naeije.
Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease.
Proc Am Thorac Soc, 2 (2005), pp. 20-22
[21]
S.M. Scharf, M. Iqbal, C. Keller, G. Criner, S. Lee, H.E. Fessler.
Hemodynamic characterization of patients with severe emphysema.
Am J Respir Crit Care Med, 166 (2002), pp. 314-322
[22]
Y. Enson, C. Giuntini, M.L. Lewis, T.Q. Morris, M.I. Ferrer, R.M. Harvey.
The influence of hydrogen ion concentration and hypoxia on the pulmonary circulation.
J Clin Invest, 43 (1964), pp. 1146-1162
[23]
J.L. Wright, T. Petty, W.M. Thurlbeck.
Analysis of the structure of the muscular pulmonary arteries in patients with pulmonary hypertension and COPD: National Institutes of Health nocturnal oxygen therapy trial.
Lung, 170 (1992), pp. 109-124
[24]
A.T. Dinh-Xuan, T.W. Higenbottam, C.A. Clelland, J. Pepke-Zaba, G. Cremona, A.Y. Butt, et al.
Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease.
N Engl J Med, 324 (1991), pp. 1539-1547
[25]
E. Weitzenblum, C. Hirth, A. Ducolone, R. Mirhom, J. Rasaholinjanahary, M. Ehrhart.
Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease.
Thorax, 36 (1981), pp. 752-758
[26]
A. Chaouat, A.S. Bugnet, N. Kadaoui, R. Schott, I. Enache, A. Ducolone, et al.
Severe pulmonary hypertension and chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 172 (2005), pp. 189-194
[27]
G. Simonneau, I.M. Robbins, M. Beghetti, R.N. Channick, M. Delcroix, C.P. Denton, et al.
Updated clinical classification of pulmonary hypertension.
J Am Coll Cardiol, 54 (2009), pp. S43-S54
[28]
S.M. Sallach, R.M. Peshock, S. Reimold.
Noninvasive cardiac imaging in pulmonary hypertension.
Cardiol Rev, 15 (2007), pp. 97-101
[29]
S.M. Arcasoy, J.D. Christie, V.A. Ferrari, M.S. Sutton, D.A. Zisman, N.P. Blumenthal, et al.
Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease.
Am J Respir Crit Care Med, 167 (2003), pp. 735-740
[30]
R. Benza, R. Biederman, S. Murali, H. Gupta.
Role of cardiac magnetic resonance imaging in the management of patients with pulmonary arterial hypertension.
J Am Coll Cardiol, 52 (2008), pp. 1683-1692
[31]
E.J. Chae, J.B. Seo, H.W. Goo, N. Kim, K.S. Song, S.D. Lee, et al.
Xenon ventilation CT with a dual-energy technique of dual-source CT: initial experience.
Radiology, 248 (2008), pp. 615-624
[32]
E.J. van Beek, E.A. Hoffman.
Functional imaging: CT and MRI.
Clin Chest Med, 29 (2008), pp. 195-216
[33]
A.L. Chan, M.M. Juárez, D.K. Shelton, T. MacDonald, C.S. Li, T.C. Lin, et al.
Novel computed tomographic chest metrics to detect pulmonary hypertension.
BMC Med Imaging, 11 (2011), pp. 7
[34]
M. Remy-Jardin, A. Duhamel, V. Deken, N. Bouaziz, P. Dumont, J. Remy.
Systemic collateral supply in patients with chronic thromboembolic and primary pulmonary hypertension: assessment with multi-detector row helical CT angiography.
Radiology, 235 (2005), pp. 274-281
[35]
C.S. Ng, A.U. Wells, S.P. Padley.
A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter.
J Thorac Imaging, 14 (1999), pp. 270-278
[36]
R.T. Tan, R. Kuzo, L.R. Goodman, R. Siegel, G.B. Haasler, K.W. Presberg.
Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease. Medical College of Wisconsin Lung Transplant Group.
Chest, 113 (1998), pp. 1250-1256
[37]
A. Bush, H. Gray, D.M. Denison.
Diagnosis of pulmonary hypertension from radiographic estimates of pulmonary arterial size.
Thorax, 43 (1988), pp. 127-131
[38]
H.G. Bogren, R.H. Klipstein, R.H. Mohiaddin, D.N. Firmin, S.R. Underwood, R.S. Rees, et al.
Pulmonary artery distensibility and blood flow patterns: a magnetic resonance study of normal subjects and of patients with pulmonary arterial hypertension.
Am Heart J, 118 (1989), pp. 990-999
[39]
R. Paz, R.H. Mohiaddin, D.B. Longmore.
Magnetic resonance assessment of the pulmonary arterial trunk anatomy, flow, pulsatility and distensibility.
Eur Heart J, 14 (1993), pp. 1524-1530
[40]
M.P. Revel, J.B. Faivre, M. Remy-Jardin, V. Delannoy-Deken, A. Duhamel, J. Remy.
Pulmonary hypertension: ECG-gated 64-section CT angiographic evaluation of new functional parameters as diagnostic criteria.
Radiology, 250 (2009), pp. 558-566
[41]
H.M. Muller, M.B. Tripolt, P.H. Rehak, R. Groell, R. Rienmuller, K.H. Tscheliessnigg.
Noninvasive measurement of pulmonary vascular resistances by assessment of cardiac output and pulmonary transit time.
Invest Radiol, 35 (2000), pp. 727-731
[42]
C.D. Vizza, J.P. Lynch, L.L. Ochoa, G. Richardson, E.P. Trulock.
Right and left ventricular dysfunction in patients with severe pulmonary disease.
Chest, 113 (1998), pp. 576-583
[43]
M. Remy-Jardin, D. Delhaye, A. Teisseire, C. Hossein-Foucher, A. Duhamel, J. Remy.
MDCT of right ventricular function: impact of methodologic approach in estimation of right ventricular ejection fraction, part 2.
Am J Roentgenol, 187 (2006), pp. 1605-1609
[44]
S. Contractor, P.D. Maldjian, V.K. Sharma, D.M. Gor.
Role of helical CT in detecting right ventricular dysfunction secondary to acute pulmonary embolism.
J Comput Assist Tomogr, 26 (2002), pp. 587-591
[45]
K.E. Lim, S.C. Tai, C.Y. Chan, Y.Y. Hsu, W.C. Hsu, B.C. Lin, et al.
Diagnosis of malpositioned chest tubes after emergency tube thoracostomy: is computed tomography more accurate than chest radiograph.
Clin Imaging, 29 (2005), pp. 401-405
[46]
M.V. Gosselin, G.D. Rubin.
Altered intravascular contrast material flow dynamics: clues for refining thoracic CT diagnosis.
Am J Roentgenol, 169 (1997), pp. 1597-1603
[47]
G. Aviram, D. Cohen, A. Steinvil, H. Shmueli, G. Keren, S. Banai, et al.
Significance of reflux of contrast medium into the inferior vena cava on computerized tomographic pulmonary angiogram.
Am J Cardiol, 109 (2012), pp. 432-437
[48]
D.K. Kang, C. Thilo, U.J. Schoepf, J.M. Barraza Jr., J.W. Nance Jr., G. Bastarrika, et al.
CT signs of right ventricular dysfunction: prognostic role in acute pulmonary embolism.
JACC Cardiovasc Imaging, 4 (2011), pp. 841-849
[49]
L.G. Rudski, W.W. Lai, J. Afilalo, L. Hua, M.D. Handschumacher, K. Chandrasekaran, et al.
Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography.
J Am Soc Echocardiogr, 23 (2010), pp. 685-713
[50]
Y. Gao, X. Du, L. Liang, L. Cao, Q. Yang, K. Li.
Evaluation of right ventricular function by 64-row CT in patients with chronic obstructive pulmonary disease and cor pulmonale.
Eur J Radiol, (2010),
[51]
J.E. Sanderson.
Heart failure with a normal ejection fraction.
Heart, 93 (2007), pp. 155-158
[52]
R.A. Takx, A. Moscariello, U.J. Schoepf, J.M. Barraza Jr., J.W. Nance Jr., G. Bastarrika, et al.
Quantification of left and right ventricular function and myocardial mass: comparison of low-radiation dose 2nd generation dual-source CT and cardiac MRI.
Eur J Radiol, 81 (2012), pp. e598-e604
[53]
R. Fischbach, K.U. Juergens, M. Ozgun, D. Maintz, M. Grude, H. Seifarth, et al.
Assessment of regional left ventricular function with multidetector-row computed tomography versus magnetic resonance imaging.
Eur Radiol, 17 (2007), pp. 1009-1017
[54]
G. Bastarrika, M. Arraiza, J.C. Pueyo, M.J. Herráiz, B. Zudaire, A. Villanueva.
Quantification of left ventricular function and mass in cardiac Dual-Source CT (DSCT) exams: comparison of manual and semiautomatic segmentation algorithms.
Eur Radiol, 18 (2008), pp. 939-946
[55]
M. Arraiza, G. Bastarrika, B. Zudaire, J. Pueyo, A. Villanueva.
Cuantificación de la función y masa ventricular izquierda mediante tomografía computarizada de doble fuente.
Radiologia, 51 (2009), pp. 148-155
[56]
G. Bastarrika, U.J. Schoepf.
Aplicaciones clínicas de la coronariografía por tomografía computarizada multicorte: ¿qué sabemos y qué más podemos saber?.
Radiologia, 51 (2009), pp. 457-468
[57]
G. Bastarrika, Y.S. Lee, B. Ruzsics, U.J. Schoepf.
Coronary CT angiography: applications.
Radiol Clin North Am, 47 (2009), pp. 91-107
[58]
D.D. Sin, L. Wu, S.F. Man.
The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature.
Chest, 127 (2005), pp. 1952-1959
[59]
S. Black, I. Kushner, D. Samols.
C-reactive protein.
J Biol Chem, 279 (2004), pp. 48487-48490
[60]
V.M. Pinto-Plata, H. Mullerova, J.F. Toso, M. Feudjo-Tepie, J.B. Soriano, R.S. Vessey, et al.
C-reactive protein in patients with COPD, control smokers and non-smokers.
Thorax, 61 (2006), pp. 23-28
[61]
M. Dahl, J. Vestbo, P. Lange, S.E. Bojesen, A. Tybjaerg-Hansen, B.G. Nordestgaard.
C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 175 (2007), pp. 250-255
[62]
W.Q. Gan, S.F. Man, A. Senthilselvan, D.D. Sin.
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis.
Thorax, 59 (2004), pp. 574-580
[63]
S.R. Salpeter, T.M. Ormiston, E.E. Salpeter.
Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis.
Chest, 125 (2004), pp. 2309-2321
[64]
E. Reyes, C.Y. Loong, K. Wechalekar, K. Latus, C. Anagnostopoulos, S.R. Underwood.
Side effect profile and tolerability of adenosine myocardial perfusion scintigraphy in patients with mild asthma or chronic obstructive pulmonary disease.
J Nucl Cardiol, 14 (2007), pp. 827-834
[65]
M.J. Budoff, S. Achenbach, R.S. Blumenthal, J.J. Carr, J.G. Goldin, P. Greenland, et al.
Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology.
Circulation, 114 (2006), pp. 1761-1791
[66]
J.A. Rumberger, B.H. Brundage, D.J. Rader, G. Kondos.
Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons.
Mayo Clin Proc, 74 (1999), pp. 243-252
[67]
Y. Arad, K.J. Goodman, M. Roth, D. Newstein, A.D. Guerci.
Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study.
J Am Coll Cardiol, 46 (2005), pp. 158-165
[68]
R. Detrano, T. Hsiai, S. Wang, G. Puentes, J. Fallavollita, P. Shields, et al.
Prognostic value of coronary calcification and angiographic stenoses in patients undergoing coronary angiography.
J Am Coll Cardiol, 27 (1996), pp. 285-290
[69]
G.T. Kondos, J.A. Hoff, A. Sevrukov, M.L. Daviglus, D.B. Garside, S.S. Devries, et al.
Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults.
Circulation, 107 (2003), pp. 2571-2576
[70]
L.J. Shaw, P. Raggi, E. Schisterman, D.S. Berman, T.Q. Callister.
Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality.
Radiology, 228 (2003), pp. 826-833
[71]
G. Bastarrika, Y.S. Lee, W. Huda, B. Ruzsics, P. Costello, U.J. Schoepf.
CT of coronary artery disease.
Radiology, 253 (2009), pp. 317-338
[72]
G. Bastarrika, U.J. Schoepf.
El radiólogo de urgencias ante el dolor torácico agudo: ¿cómo y para qué debo utilizar los equipos TC multicorte?.
Radiologia, 53 (2011), pp. 30-42
